Profil
Martin Henry Diggle founded Vulpes Investment Management Ltd., where he is working as Director & Partner from 2015.
Mr. Diggle also currently works at Vulpes Life Sciences Fund, as Chairman, Proteome Sciences Plc, as Non-Executive Director from 2014, Oxford BioDynamics Plc, as Non-Executive Director from 2026, and Vulpes Ventures, as Portfolio Manager.
Mr. Diggle also formerly worked at Oxford Biomedica Plc, as Non-Independent Non-Executive Director from 2012 to 2021, Brunswick UBS, as Director & Partner, Scancell Holdings Plc, as Non-Executive Director, Leucid Bio Ltd., as Director, and Chronos Therapeutics Ltd., as Non-Executive Director.
Mr. Diggle received his graduate degree from the University of Oxford.
Postes actifs de Martin Diggle
| Sociétés | Poste | Début |
|---|---|---|
| PROTEOME SCIENCES PLC | Directeur/Membre du Conseil | 16/10/2014 |
| OXFORD BIODYNAMICS PLC | Directeur/Membre du Conseil | 15/04/2026 |
Vulpes Investment Management Ltd.
Vulpes Investment Management Ltd. Investment ManagersFinance Provides investment advice | Directeur/Membre du Conseil | 27/03/2015 |
Vulpes Investment Management Pte Ltd. (Venture Capital)
Vulpes Investment Management Pte Ltd. (Venture Capital) Investment ManagersFinance Vulpes Ventures invests in companies located in Southeast Asia, Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Vulpes Life Sciences Fund
Vulpes Life Sciences Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Président | - |
Anciens postes connus de Martin Diggle
| Sociétés | Poste | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Directeur/Membre du Conseil | 03/02/2021 |
Brunswick UBS
Brunswick UBS Investment Banks/BrokersFinance Operates as a investment bank | Directeur/Membre du Conseil | 01/01/2003 |
Leucid Bio Ltd.
Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that develops next generation CAR-T therapy | Directeur/Membre du Conseil | - |
| SCANCELL HOLDINGS PLC | Directeur/Membre du Conseil | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Martin Diggle
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Proteome Sciences Plc
Proteome Sciences Plc Medical SpecialtiesHealth Technology Develops medical diagnostics used to identify specific diseases | Health Technology |
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brunswick UBS
Brunswick UBS Investment Banks/BrokersFinance Operates as a investment bank | Finance |
Scancell Holdings Plc
Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Oxford BioDynamics Plc
Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Vulpes Investment Management Ltd.
Vulpes Investment Management Ltd. Investment ManagersFinance Provides investment advice | Finance |
Vulpes Life Sciences Fund
Vulpes Life Sciences Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Miscellaneous |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Develops therapies in degenerative and behavioral brain diseases | Health Technology |
Vulpes Investment Management Pte Ltd. (Venture Capital)
Vulpes Investment Management Pte Ltd. (Venture Capital) Investment ManagersFinance Vulpes Ventures invests in companies located in Southeast Asia, Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Leucid Bio Ltd.
Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that develops next generation CAR-T therapy | Commercial Services |
















